Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.
复制标题
DOI:
10.1161/circulationaha.111.040311
复制
发表时间:
2012-02-14
期刊:
影响因子:
37.8
通讯作者:
Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) Investigators
中科院分区:
文献类型:
--
作者:
Lopes RD;Mehta RH;Hafley GE;Williams JB;Mack MJ;Peterson ED;Allen KB;Harrington RA;Gibson CM;Califf RM;Kouchoukos NT;Ferguson TB Jr;Alexander JH;Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) Investigators
Vein graft failure (VGF) is common after coronary artery bypass graft surgery, but its relationship with long-term clinical outcomes is unknown. In this retrospective analysis, we examined the relationship between VGF, assessed by coronary angiography 12 to 18 months after coronary artery bypass graft surgery, and subsequent clinical outcomes. Using the Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) trial database, we studied data from 1829 patients who underwent coronary artery bypass graft surgery and had an angiogram performed up to 18 months after surgery. The main outcome measure was death, myocardial infarction, and repeat revascularization through 4 years after angiography. VGF occurred in 787 of 1829 patients (43%). Clinical follow-up was completed in 97% of patients with angiographic follow-up. The composite of death, myocardial infarction, or revascularization occurred more frequently among patients who had any VGF compared with those who had none (adjusted hazard ratio, 1.58; 95% confidence interval, 1.21–2.06; P=0.008). This was due mainly to more frequent revascularization with no differences in death (adjusted hazard ratio, 1.04; 95% confidence interval, 0.71–1.52; P=0.85) or death or myocardial infarction (adjusted hazard ratio, 1.08; 95% confidence interval, 0.77–1.53; P=0.65). VGF is common after coronary artery bypass graft surgery and is associated with repeat revascularization but not with death and/or myocardial infarction. Further investigations are needed to evaluate therapies and strategies for decreasing VGF to improve outcomes in patients undergoing coronary artery bypass graft surgery.